[
  {
    "ts": null,
    "headline": "AbbVie: Rocky Near-Term, Positive Long-Term",
    "summary": "AbbVie (ABBV) 2026 outlook: valuation, MFN risks, cyclicals shift, and long-term immunology & dividend strengths.",
    "url": "https://finnhub.io/api/news?id=0001afd40b53e2f75b63e6a60fbeda83f1ee8ee1ae403af6f4773affed3ca8f7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767517450,
      "headline": "AbbVie: Rocky Near-Term, Positive Long-Term",
      "id": 137980846,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2175801616/image_2175801616.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie (ABBV) 2026 outlook: valuation, MFN risks, cyclicals shift, and long-term immunology & dividend strengths.",
      "url": "https://finnhub.io/api/news?id=0001afd40b53e2f75b63e6a60fbeda83f1ee8ee1ae403af6f4773affed3ca8f7"
    }
  }
]